Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA
- PMID: 16362162
- DOI: 10.1007/s10157-005-0382-7
Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA
Abstract
We describe a 75-year-old man with tubulointerstitial nephritis (TIN) with myeloperoxidase (MPO)-antineutrophil antibody (ANCA) and proteinase-3 (PR3)-ANCA. He had a slight fever and eruption with itching after taking cimetidine (prescribed after gastrectomy for gastric cancer) and he was admitted to a nearby hospital. There, he showed proteinuria, serum creatinine (sCr) of 2.9 mg/dl, and creatinine clearance (Ccr) of 44 ml/min per 1.73 m2. His MPO-ANCA titer was 267 EU, and PR3-ANCA titer was 112 EU. Abnormal concentrations in bilateral kidneys were found by gallium scintigraphy. For these reasons, he was transferred to our hospital. Percutaneous renal biopsy was performed after admission. Severe tubular atrophy, mild interstitial fibrosis, and severe mononuclear cell infiltration of the interstitium were noted. Drug-induced renal impairment was suspected, and cimetidine administration was withdrawn. Lymphocyte stimulation tests (DLSTs) were performed. The cimetidine titer was positive, at 2,537 cpm. After the withdrawal of cimetidine, the PR3-ANCA titer was reduced gradually, and, next, the MPO-ANCA titer was also reduced. The sCr level was reduced to 1.2 mg/dl. In summary, we report herein the first case of cimetidine-induced TIN associated with both MPO-ANCA and PR3-ANCA.
Similar articles
-
A case of cimetidine-induced acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody.Am J Kidney Dis. 1999 Feb;33(2):E7. doi: 10.1016/s0272-6386(99)70328-8. Am J Kidney Dis. 1999. PMID: 10074607
-
Acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody following cimetidine treatment: a case report.BMC Nephrol. 2021 Aug 30;22(1):294. doi: 10.1186/s12882-021-02502-y. BMC Nephrol. 2021. PMID: 34461843 Free PMC article. Review.
-
Differences in clinico-pathological characteristics and outcomes between proteinase 3-ANCA positivity and myeloperoxidase-ANCA positivity in lupus nephritis.Lupus. 2019 Aug;28(9):1111-1119. doi: 10.1177/0961203319861680. Epub 2019 Jul 10. Lupus. 2019. PMID: 31291845
-
IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.Arthritis Rheum. 2001 Apr;44(4):921-30. doi: 10.1002/1529-0131(200104)44:4<921::AID-ANR149>3.0.CO;2-4. Arthritis Rheum. 2001. PMID: 11315931
-
Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.Kidney Int. 2000 Jun;57(6):2195-206. doi: 10.1046/j.1523-1755.2000.00080.x. Kidney Int. 2000. PMID: 10844589 Review.
Cited by
-
A Glimpse into Humoral Response and Related Therapeutic Approaches of Takayasu's Arteritis.Int J Mol Sci. 2024 Jun 13;25(12):6528. doi: 10.3390/ijms25126528. Int J Mol Sci. 2024. PMID: 38928233 Free PMC article. Review.
-
A Japanese case of proteinase 3 antineutrophil cytoplasmic autoantibody-associated pauci-immune-type crescentic glomerulonephritis without valvular endocarditis.Clin Exp Nephrol. 2011 Jun;15(3):419-423. doi: 10.1007/s10157-011-0407-3. Epub 2011 Feb 18. Clin Exp Nephrol. 2011. PMID: 21331743
-
A Rare Case of Anca Positivity and Antiphospholipid Antibodies in a Patient with Takayasu Arteritis: Case Report and Review of the Literature.Biomedicines. 2023 Oct 18;11(10):2826. doi: 10.3390/biomedicines11102826. Biomedicines. 2023. PMID: 37893200 Free PMC article.
-
Rare Case of Renal Limited Dual Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Double Trouble!Eur J Case Rep Intern Med. 2022 May 10;9(5):003365. doi: 10.12890/2022_003365. eCollection 2022. Eur J Case Rep Intern Med. 2022. PMID: 35774735 Free PMC article.
-
Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.Rheumatol Int. 2019 Nov;39(11):1919-1926. doi: 10.1007/s00296-019-04447-w. Epub 2019 Sep 24. Rheumatol Int. 2019. PMID: 31552433
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous